ESC 365 - Treatment strategies targeting TTR amyloid in hATTR amyloidosis (a multi-system disease).

Open Access

Treatment strategies targeting TTR amyloid in hATTR amyloidosis (a multi-system disease).

Session: New targets to enhance survival and outcomes in hATTR amyloidosis

Topic: Clinical

Speaker: Doctor H. Nienhuis (Groningen, NL)

Sponsored by Alnylam Pharmaceuticals

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Doctor Hans Nienhuis

Groningen (Netherlands (The))

2 presentations

0 follower

3 more presentations in this session

Welcome and introduction: the origin and evolution of the disease.

Speaker: Professor T. Damy (Creteil, FR)

Update on RNAi therapy in hATTR amyloidosis.

Speaker: Doctor P. Garcia-Pavia (Majadahonda, ES)

Discussion and closing remarks.

Speaker: Professor T. Damy (Creteil, FR) Doctor H. Nienhuis (Groningen, NL) Doctor P. Garcia-Pavia (Majadahonda, ES)

Access the full session

New targets to enhance survival and outcomes in hATTR amyloidosis

Speakers: Doctor H. Nienhuis, Professor T. Damy, Doctor P. Garcia-Pavia, Professor T. Damy, Doctor H. Nienhuis...

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources